Showing results (171-180 of 196) with videos related to
Sort By:
Pageof 20
Leukemia|July 8, 2020
miR-21 antagonism abrogates Th17 tumor promoting functions in multiple myelomaMarco Rossi, Emanuela Altomare, Cirino Botta, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 10, 2013
Gemcitabine, oxaliplatin, levofolinate, 5-fluorouracil, granulocyte-macrophage colony-stimulating factor, and interleukin-2 (GOLFIG) versus FOLFOX chemotherapy in metastatic colorectal cancer patients: the GOLFIG-2 multicentric open-label randomized phase III trialPierpaolo Correale, Cirino Botta, Maria S Rotundo, et al.Blood|July 13, 2018
Therapeutic vulnerability of multiple myeloma to MIR17PTi, a first-in-class inhibitor of pri-miR-17-92Eugenio Morelli, Lavinia Biamonte, Cinzia Federico, et al.Cells|August 29, 2020
HLA Expression Correlates to the Risk of Immune Checkpoint Inhibitor-Induced PneumonitisPierpaolo Correale, Rita Emilena Saladino, Diana Giannarelli, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 5, 2012
Synthetic miR-34a mimics as a novel therapeutic agent for multiple myeloma: in vitro and in vivo evidenceMaria T Di Martino, Emanuela Leone, Nicola Amodio, et al.Molecular Therapy. Nucleic Acids|April 23, 2019
miR-125b Upregulates miR-34a and Sequentially Activates Stress Adaption and Cell Death Mechanisms in Multiple MyelomaGabriella Misso, Mayra Rachele Zarone, Angela Lombardi, et al.Molecular Therapy. Nucleic Acids|April 10, 2025
Erratum: miR-125b Upregulates miR-34a and Sequentially Activates Stress Adaption and Cell Death Mechanisms in Multiple MyelomaGabriella Misso, Mayra Rachele Zarone, Angela Lombardi, et al.Tumori|October 13, 2011
Disparity in the "time to patient access" to new anti-cancer drugs in Italian regions. Results of a survey conducted by the Italian Society of Medical Oncology (AIOM)Stefania Gori, Massimo Di Maio, Carmine Pinto, et al.Tumori|April 4, 2013
Impact of use of oral anticancer drugs on activity of Italian oncology practices: results of a survey conducted by the Italian Society of Medical Oncology (AIOM)Stefania Gori, Massimo Di Maio, Carmine Pinto, et al.Life (Basel, Switzerland)|November 27, 2021
Distinctive Role of the Systemic Inflammatory Profile in Non-Small-Cell Lung Cancer Younger and Elderly Patients Treated with a PD-1 Immune Checkpoint Blockade: A Real-World Retrospective Multi-Institutional AnalysisValerio Nardone, Rocco Giannicola, Diana Giannarelli, et al.Pageof 20